InfuSystem Holdings (INFU) Acquisitions (2010 - 2021)

InfuSystem Holdings' (INFU) quarterly Acquisitions came in at $400000.0 in Q4 2021, up 150.0% on a QoQ basis from $160000.0 in Q3 2021.

InfuSystem Holdings (INFU) Acquisitions (2010 - 2021) Analysis & Trends

InfuSystem Holdings (INFU) has 5 years of Acquisitions data on file, last reported at $400000.0 in Q4 2021.

Quarterly Acquisitions changed N/A year-over-year to $400000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $400000.0 (down 94.77% YoY) and the FY2025 annual result came in at $1.4 million, changed N/A from the prior year.
Acquisitions climbed to $400000.0 in Q4 2021, from $160000.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $6.3 million in Q2 2021 to a low of $160000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	-
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	437.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-4.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-3.49 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	16.00 Mn
10	InfuSystem Holdings	244.67 Mn	243.70 Mn	21.41 Mn	-

Download Data